BioArctic AB Class B Statistics
BioArctic AB Class B (0RV2) Stock Statistics & Valuation Metrics
Total Valuation
BioArctic AB Class B has a market cap or net worth of SEK 27.05B. The enterprise value is SEK 27.31B.
- Market Cap
- SEK 27.05B
- Enterprise Value
- SEK 27.31B
Share Statistics
BioArctic AB Class B has 74,344,690 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 74,344,690
- Owned by Insiders
- ―
- Owned by Institutions
- 5.80%
Financial Efficiency
BioArctic AB Class B’s return on equity (ROE) is 0.52 and return on invested capital (ROIC) is 53.81%.
- Return on Equity (ROE)
- 0.52
- Return on Assets (ROA)
- 0.40
- Return on Invested Capital (ROIC)
- 53.81%
- Return on Capital Employed (ROCE)
- 0.67
- Revenue Per Employee
- 13.33M
- Profits Per Employee
- 6.82M
- Employee Count
- 150
- Asset Turnover
- 0.78
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of BioArctic AB Class B is 256.13. BioArctic AB Class B’s PEG ratio is -2.84.
- PE Ratio
- 256.13
- PS Ratio
- 26.98
- PB Ratio
- 13.41
- Price to FCF
- 254.85
- Price to Operating Cash Flow
- 110.84
- PEG Ratio
- -2.84
Income Statement
In the last 12 months, BioArctic AB Class B had revenue of 2.00B and earned 1.02B in profits. Earnings per share was 11.55.
- Revenue
- 2.00B
- Gross Profit
- 1.94B
- Operating Income
- 1.37B
- Pretax Income
- 1.26B
- Net Income
- 1.02B
- EBITDA
- 1.38B
- Earnings Per Share (EPS)
- 11.55
Cash Flow
In the last 12 months, operating cash flow was 243.98M and capital expenditures -451.17M, giving a free cash flow of 106.14M billion.
- Operating Cash Flow
- 243.98M
- Free Cash Flow
- 106.14M
- Free Cash Flow per Share
- 1.20
Dividends & Yields
BioArctic AB Class B pays an annual dividend of ―, resulting in a dividend yield of 0.68%
- Dividend Per Share
- ―
- Dividend Yield
- 0.68%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.39%
- Earnings Yield
- 0.39%
Stock Price Statistics
- Beta
- 0.46
- 52-Week Price Change
- 5.64%
- 50-Day Moving Average
- 310.01
- 200-Day Moving Average
- 315.87
- Relative Strength Index (RSI)
- 45.26
- Average Volume (3m)
- 6,404
Important Dates
BioArctic AB Class B upcoming earnings date is Nov 25, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- Nov 25, 2026
- Ex-Dividend Date
- ―
Financial Position
BioArctic AB Class B as a current ratio of 4.78, with Debt / Equity ratio of 2.24%
- Current Ratio
- 4.78
- Quick Ratio
- 4.78
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.72
- Interest Coverage Ratio
- 36.10
Taxes
In the past 12 months, BioArctic AB Class B has paid 233.26M in taxes.
- Income Tax
- 233.26M
- Effective Tax Rate
- 0.19
Enterprise Valuation
BioArctic AB Class B EV to EBITDA ratio is 114.45, with an EV/FCF ratio of 245.51.
- EV to Sales
- 25.99
- EV to EBITDA
- 114.45
- EV to Free Cash Flow
- 245.51
- EV to Operating Cash Flow
- 106.81
Balance Sheet
BioArctic AB Class B has SEK 1.99B in cash and marketable securities with SEK 90.61M in debt, giving a net cash position of SEK 1.90B billion.
- Cash & Marketable Securities
- SEK 1.99B
- Total Debt
- SEK 90.61M
- Net Cash
- SEK 1.90B
- Net Cash Per Share
- SEK 25.55
- Tangible Book Value Per Share
- SEK 22.72
Margins
Gross margin is 93.17%, with operating margin of 21.37%, and net profit margin of 10.53%.
- Gross Margin
- 93.17%
- Operating Margin
- 21.37%
- Pretax Margin
- 24.80%
- Net Profit Margin
- 10.53%
- EBITDA Margin
- 22.71%
- EBIT Margin
- 21.43%
Analyst Forecast
The average price target for BioArctic AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -46.09%
- EPS Growth Forecast
- -90.13%

